Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
1.520
-0.490 (-24.38%)
At close: Sep 15, 2026, 4:00 PM EDT
1.575
+0.055 (3.63%)
After-hours: Sep 15, 2026, 7:48 PM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $24.75 million as of September 15, 2026. Its market cap has decreased by -49.13% in one year.
Market Cap
24.75M
Enterprise Value
20.11M
1-Year Change
-49.13%
Ranking
Category
Stock Price
$1.52
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $24.75M, a decrease of -66.03%. That is a compound annual growth rate of -20.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 24.75M | -58.13% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TransCode Therapeutics | 27.09M |
| Estrella Immunopharma | 26.58M |
| CEL-SCI | 26.03M |
| Evaxion | 25.35M |
| Polyrizon | 23.97M |
| NanoViricides | 23.92M |
| Atossa Therapeutics | 23.65M |
| Actuate Therapeutics | 23.62M |